In January 2025, Sagimet delivered an oral presentation at the 9 th Annual MASH-TAG Conference highlighting the ...

Sagimet Biosciences, Inc. Class A ( ($SGMT) ) has released its Q1 earnings. Here is a breakdown of the information Sagimet Biosciences, Inc. Class ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...

SGMT), clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in ...

Researchers at Peking University have discovered that a filamentous gut fungus, Fusarium foetens, can reverse metabolic ...

Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to ...

Omega-3 fatty acids are vital for women's health, supporting heart and brain function, hormone regulation, and reducing inflammation. Since the body can't produce them, incorporating fatty fish ...

Women’s fat cells break down fat faster than men’s once activated, even though they require higher hormone levels to initiate ...

Imagine if agricultural and food byproducts could be transformed into an effective and holistic feed for livestock while also ...

New research being presented at this year's European Congress on Obesity (ECO 2025) has explored the differences in how the ...